about
Endoplasmic reticulum quality control and systemic amyloid disease: Impacting protein stability from the inside outClinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.ATF6 activation reduces the secretion and extracellular aggregation of destabilized variants of an amyloidogenic protein.A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.Nationwide renal biopsy data in Lithuania 1994-2012.Primary systemic amyloidosis as a real diagnostic challenge - case study.Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.Prions and prion-like pathogens in neurodegenerative disorders.Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT.An elderly male with tingly legs and a heavy heart: Persisting with the diagnosis!A Rare Case of Amyloidosis of the Eyelid and Conjunctiva.Upper Gastrointestinal Bleeding from Gastric Amyloidosis in a Patient with Smoldering Multiple Myeloma.Massive Upper and Lower GI Bleed from Simultaneous Primary (AL) Amyloidosis of the Stomach and Transverse Colon in a Patient with Multiple Myeloma.Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.Clinical characteristics and diagnosis of a rare case of systemic AL amyloidosis: a descriptive study.Isolated Laryngeal Amyloidosis Mimicking Laryngeal Cancer
P2860
Q28084013-3D1A1F7D-2AF8-4AD9-B487-9660D9B86F13Q33677011-B27DEF08-5198-437A-A8D2-99BB9CFF5885Q34625989-72A9EB3A-97FD-4351-A178-E232030820D1Q35552353-2F8B3B33-6760-4E69-AD25-F6C9252278D4Q35562206-9C7E7B0C-012F-4272-A825-72F7EE9F187DQ35631725-8DBD3D42-BC9B-42A0-B422-C5AFC7DBDE87Q35940703-0DB84276-ECF0-4B42-A835-1CACA1BB1D8EQ36528525-5ABEB2BD-2A96-4572-8F2D-0088CE94602EQ38273271-52D07519-015A-407C-AF34-E00A855153AFQ38402309-291DA3B1-F034-4FAC-AAAB-B48B709C9EF6Q39043920-12F97893-912D-4195-8CB1-0BFBD0C6F40EQ41379529-2DD6BDBB-AF0B-44C6-96AC-4C72DB43B200Q41957641-890E9FA6-001B-465E-8FC5-41C05F4C7AA7Q47169010-54146BC5-2462-441A-BEF0-793DA51A734BQ52957195-F4F169E5-3919-451F-823B-2356E8C2548BQ55411132-000289FD-52C8-4657-992A-F4CB791DB8EAQ58798131-879C27C1-B3C0-411D-8C6F-FAE0F6BDF4FA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathophysiology and treatment of systemic amyloidosis.
@en
type
label
Pathophysiology and treatment of systemic amyloidosis.
@en
prefLabel
Pathophysiology and treatment of systemic amyloidosis.
@en
P2860
P356
P1476
Pathophysiology and treatment of systemic amyloidosis.
@en
P2093
Julian D Gillmore
Philip N Hawkins
P2860
P2888
P304
P356
10.1038/NRNEPH.2013.171
P407
P577
2013-08-27T00:00:00Z